Abstract
Eight peptides were isolated from Bothrops moojeni venom by filtration followed by HPLC. MALDI mass spectroscopy and Edman degradation determined the purity, Mr and sequence of the peptides, respectively. Three (BmP7, BmP8 and BmvP11) of them were homologues with the biologically active B. jararaca bradykinin potentiating peptides while the other with peptides or protein from different sources.
Keywords: Bothrops moojeni, BRADYKININ, algesic hypotensive substance, Kininogenases, angiotensin I to II, angiotensin convertase, antihypertensive drugs, bradykinin potentiating peptides (BPPs)
Protein & Peptide Letters
Title: Bothrops Moojeni Venom Peptides Containing Bradykinin Potentiating Peptides Sequences
Volume: 8 Issue: 1
Author(s): S. C. Bourguignon, F. S. Paes, E. B. Calheiros, M. Juliano, A. S. Aguiar, A. R. Melgarejo and S. Giovanni-De-Simone
Affiliation:
Keywords: Bothrops moojeni, BRADYKININ, algesic hypotensive substance, Kininogenases, angiotensin I to II, angiotensin convertase, antihypertensive drugs, bradykinin potentiating peptides (BPPs)
Abstract: Eight peptides were isolated from Bothrops moojeni venom by filtration followed by HPLC. MALDI mass spectroscopy and Edman degradation determined the purity, Mr and sequence of the peptides, respectively. Three (BmP7, BmP8 and BmvP11) of them were homologues with the biologically active B. jararaca bradykinin potentiating peptides while the other with peptides or protein from different sources.
Export Options
About this article
Cite this article as:
Bourguignon C. S., Paes S. F., Calheiros B. E., Juliano M., Aguiar S. A., Melgarejo R. A. and Giovanni-De-Simone S., Bothrops Moojeni Venom Peptides Containing Bradykinin Potentiating Peptides Sequences, Protein & Peptide Letters 2001; 8 (1) . https://dx.doi.org/10.2174/0929866013409689
DOI https://dx.doi.org/10.2174/0929866013409689 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Protein Profile Analysis of Two Australian Snake Venoms by One- Dimensional Gel Electrophoresis and MS/MS Experiments
Current Medicinal Chemistry Acute Kidney Injury: Turning the Tide
Current Drug Targets Radix Astragali (Astragalus): Latest Advancements and Trends in Chemistry, Analysis, Pharmacology and Pharmacokinetics
Current Organic Chemistry The Nitric Oxide Prodrug JS-K and Its Structural Analogues as Cancer Therapeutic Agents
Anti-Cancer Agents in Medicinal Chemistry A Comparative Effectiveness Systematic Review and Meta-analysis of Drugs for the Prophylaxis of Junctional Ectopic Tachycardia
Current Cardiology Reviews An Update on Drug Interactions with the Herbal Medicine Ginkgo biloba
Current Drug Metabolism Angiotensin Converting Enzyme Inhibitory Peptides Derived from Food Proteins: Biochemistry, Bioactivity and Production
Current Pharmaceutical Design Effect of the Antihypertensive Treatment on the Bone Mineral Density and Osteoporotic Fracture
Current Hypertension Reviews Under-Dosing of Etomidate for Rapid Sequence Intubation in the Emergency Department
Current Drug Safety Efficacy and Safety of H1-Antihistamines: An Update
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Updated Role of the Blood Brain Barrier in Subarachnoid Hemorrhage: From Basic and Clinical Studies
Current Neuropharmacology Oxytocin in the Heart Regeneration
Recent Patents on Cardiovascular Drug Discovery Targets and Tools: Recent Advances in the Development of Anti-HCV Nucleic Acids
Infectious Disorders - Drug Targets α-Synuclein Misfolding and Neurodegenerative Diseases
Current Protein & Peptide Science Urocortin: Cardiovascular Actions and Therapeutic Implications
Letters in Drug Design & Discovery MicroRNAs as Diagnostic, Prognostic and Predictive Biomarkers of Cardiac Disease
Recent Patents on Biomarkers Regulation of Angiogenesis by the Kallikrein-Kinin System
Current Pharmaceutical Design Role of WNK Kinases in Blood Pressure Control
Current Hypertension Reviews Hypertension in Diabetes: Optimal Pharmacotherapy
Cardiovascular & Hematological Agents in Medicinal Chemistry Effect of an Angiotensin II Receptor Blocker and Two Angiotensin Converting Enzyme Inhibitors on Transforming Growth Factor-β (TGF-β) and α-Actomyosin (α SMA), Important Mediators of Radiation-Induced Pneumopathy and Lung Fibrosis
Current Pharmaceutical Design